| BSE: 532321 | Sector: Health care |
| NSE: CADILAHC | ISIN Code: INE010B01027 |
| BSE 00:00 | 22 Jan | 345.25 |
0.55 (0.16%) |
OPEN
344.35 |
HIGH
346.60 |
LOW
339.75 |
| NSE 00:00 | 22 Jan | 346.05 |
1.45 (0.42%) |
OPEN
343.95 |
HIGH
347.60 |
LOW
340.30 |
| OPEN | 344.35 |
| PREVIOUS CLOSE | 344.70 |
| VOLUME | 50483 |
| 52-Week high | 445.00 |
| 52-Week low | 330.65 |
| P/E | 23.16 |
| Mkt Cap.(Rs cr) | 35,343 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cadila Healthcare Ltd is a well known research-oriented technology-driven pharmaceutical company focused on the research areas of biotechnology formulations and Active Pharmaceutical Ingredients. They are an Indian based pharmaceutical company having their presence around the world. They are having their manufacturing facilities at Ahmedabad Ankleshwar and Vadodara in Gujarat Ponda in Goa Raigad i...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
35,343 | |
| EPS - TTM | () |
[*S] | 14.91 |
| P/E Ratio | (X) | [*S] | 23.16 |
| Face Value | () |
1 | |
| Latest Dividend | (%) | 350.00 | |
| Latest Dividend Date | 31 Jul 2018 | ||
| Dividend Yield | (%) | 1.01 | |
| Book Value / Share | () |
[*S] | 81.48 |
| P/B Ratio | () |
[*S] | 4.24 |
Cadila Healthcare posts 17% dip in Q2 net to Rs 4.1 bn; revenue down 8.1%
Zydus Cadila gets tentative US FDA nod for diabetes drug Linagliptin
Zydus Cadila to enter $68-mn market after US FDA nod for breast cancer drug
Cadila Healthcare plans to launch 50 products in US market in FY19
Cadila Healthcare nears 52-week low post June quarter results
Particulars ( cr) |
Sep 2018 | Sep 2017 | % Chg |
| Net Sales | 2961.2 | 3221.9 | -8.09 |
| Other Income | 30.4 | 22.5 | 35.11 |
| Total Income | 2991.6 | 3244.4 | -7.79 |
| Total Expenses | 2273.4 | 2365.3 | -3.89 |
| Operating Profit | 718.2 | 879.1 | -18.3 |
| Net Profit | 410.3 | 500 | -17.94 |
| Equity Capital | 102.4 | 102.4 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Biocon | 668.30 | 0.77 | 40098.00 |
| Divi's Lab. | 1502.40 | 0.30 | 39881.21 |
| Lupin | 863.20 | -0.27 | 39051.17 |
| Cadila Health. | 345.25 | 0.16 | 35343.24 |
| Torrent Pharma. | 1913.65 | 1.88 | 32382.79 |
| Glaxosmi. Pharma | 1416.80 | 1.29 | 24002.01 |
| Alkem Lab | 1886.70 | -0.67 | 22555.50 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -2.84% | -2.77% | 0.35% | 0.33% |
| 1 Month | 0.94% | 1.21% | 1.97% | 1.57% |
| 3 Month | -7.55% | -7.23% | 6.77% | 6.61% |
| 6 Month | -0.22% | -0.55% | -0.14% | -0.79% |
| 1 Year | -21.42% | -21.13% | 1.81% | -0.40% |
| 3 Year | 14.78% | 14.99% | 49.15% | 47.16% |
| Today's Low/High | 339.75 |
|
346.60 |
| Week Low/High | 339.75 |
|
360.00 |
| Month Low/High | 336.65 |
|
360.00 |
| YEAR Low/High | 330.65 |
|
445.00 |
| All TIME Low/High | 5.53 |
|
558.00 |
Copyrights © 2019 Business Standard Private Ltd. All rights reserved.
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
Details